• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关注声明:小分子LLL12可抑制组成型STAT3以及白细胞介素-6诱导的STAT3信号传导,并在人多发性骨髓瘤细胞中表现出强大的生长抑制活性。

EXPRESSION OF CONCERN: A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.

出版信息

FEBS Lett. 2024 Nov;598(21):2748. doi: 10.1002/1873-3468.15037. Epub 2024 Oct 11.

DOI:10.1002/1873-3468.15037
PMID:39394476
Abstract

Expression of Concern: H. Wang, B. Wang, Q. Liao, H. An, W. Li, X. Jin, S. Cui, and L. Zhao, "Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma," FEBS Letters 588, no. 3 (2014): 503-508. https://doi.org/10.1016/j.febslet.2013.12.016. This Expression of Concern is for the above article, published online on 24 December 2013, in Wiley Online Library (wileyonlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief Michael Brunner; FEBS Press; and John Wiley and Sons Ltd. The Expression of Concern has been agreed due to concerns raised by a third party regarding the similarity of beta-actin blots in Fig. 3A between the HepG2 and the MHCC-97H lanes. The authors responded to an inquiry by the publisher and supplied what was labelled as original data. However, following an evaluation of the authors' response by FEBS and the editors, Wiley and the journal have determined that they are unable to verify if the files provided by the authors correspond to the research described in the article. The journal is issuing this Expression of Concern because the results of the experiment as presented cannot be confirmed. The authors do not agree with the expression of concern.

摘要

关注声明

H. Wang、B. Wang、Q. Liao、H. An、W. Li、X. Jin、S. Cui和L. Zhao,“RhoGDI的过表达,一种远处转移的新型预测因子,促进肝细胞癌的细胞增殖和迁移”,《欧洲生物化学学会联合会快报》588卷,第3期(2014年):503 - 508页。https://doi.org/10.1016/j.febslet.2013.12.016 。本关注声明针对上述于2013年12月24日在线发表于Wiley Online Library(wileyonlinelibrary.com)的文章,由期刊主编Michael Brunner、欧洲生物化学学会联合会出版社以及John Wiley and Sons Ltd.协商发布。发布此关注声明是由于第三方对图3A中HepG2和MHCC - 97H泳道之间β - 肌动蛋白印迹的相似性提出了担忧。作者回复了出版商的询问并提供了标记为原始数据的资料。然而,在欧洲生物化学学会联合会和编辑对作者的回复进行评估后,Wiley和期刊确定无法核实作者提供的文件是否与文章中描述的数据相符。该期刊发布此关注声明是因为所呈现的实验结果无法得到证实。作者不同意发布此关注声明。

相似文献

1
EXPRESSION OF CONCERN: A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.关注声明:小分子LLL12可抑制组成型STAT3以及白细胞介素-6诱导的STAT3信号传导,并在人多发性骨髓瘤细胞中表现出强大的生长抑制活性。
FEBS Lett. 2024 Nov;598(21):2748. doi: 10.1002/1873-3468.15037. Epub 2024 Oct 11.
2
Retraction: Wang C, Chen Z, Ge Q, Hu J, Li F, Hu J, Xu H, Ye Z, Li LC (2014) Up-regulation of p21 by miRNAs and its implications in bladder cancer cells. FEBS Letters 588, 4654-4664. https://doi.org/10.1016/j.febslet.2014.10.037.撤回声明:王C、陈Z、葛Q、胡J、李F、胡J、徐H、叶Z、李LC(2014年)。miRNA对p21的上调作用及其在膀胱癌细胞中的意义。《欧洲生物化学学会联合会快报》588卷,4654 - 4664页。https://doi.org/10.1016/j.febslet.2014.10.037 。
FEBS Lett. 2024 Jun;598(11):1449. doi: 10.1002/1873-3468.14892. Epub 2024 May 15.
3
RETRACTION: Selection for TRAIL Resistance Results in Melanoma Cells with High Proliferative Potential.撤稿声明:对TRAIL抗性的选择导致具有高增殖潜力的黑色素瘤细胞。
FEBS Lett. 2024 Oct;598(20):2615. doi: 10.1002/1873-3468.15028. Epub 2024 Sep 27.
4
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.撤稿声明:丁,J.,王,X.,高,J. 和宋,T.(2021年),胱抑素SN沉默可消除甲状腺乳头状癌的癌症进展和干细胞特性。《欧洲生物化学学会联合会开放生物学》,11: 2186 - 2197。
FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
5
RETRACTION: Role of the PDK1-PKB-GSK3 Pathway in Regulating Glycogen Synthase and Glucose Uptake in the Heart.撤回声明:PDK1-PKB-GSK3信号通路在调节心脏糖原合酶和葡萄糖摄取中的作用。
FEBS Lett. 2024 Dec;598(23):2939. doi: 10.1002/1873-3468.15044. Epub 2024 Oct 24.
6
RETRACTION: CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10.撤回声明:环状RNA EPHB4通过吸附miR-637并上调SOX10来调节胶质瘤的干性和增殖。
Mol Oncol. 2024 Oct;18(10):2603. doi: 10.1002/1878-0261.13693. Epub 2024 Jul 1.
7
RETRACTION: MeCP2 Drives Hepatocellular Carcinoma Progression Via Enforcing HOXD3 Promoter Methylation and Expression Through the HB-EGF/EGFR Pathway.撤稿声明:MeCP2 通过 HB-EGF/EGFR 途径增强 HOXD3 启动子甲基化和表达来驱动肝细胞癌进展。
Mol Oncol. 2024 Aug;18(8):2061. doi: 10.1002/1878-0261.13681. Epub 2024 Jun 5.
8
RETRACTION: The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.撤稿声明:长链非编码RNA AK002107负向调控miR-140-5p并靶向转化生长因子β受体1以诱导肝细胞癌上皮-间质转化
Mol Oncol. 2024 Aug;18(8):2062. doi: 10.1002/1878-0261.13677. Epub 2024 Jun 14.
9
RETRACTION: Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 Via NFKB1 Transcriptional Factor.撤稿声明:长链非编码RNA SLC26A4-AS1通过NFKB1转录因子上调NPTX1在人胶质瘤中发挥抗血管生成作用。
FEBS J. 2024 Oct;291(20):4633. doi: 10.1111/febs.17268. Epub 2024 Sep 30.
10
RETRACTION: Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.撤回声明:在系统性红斑狼疮中,Bach2过表达通过抑制IRF4表达来抑制Th9细胞分化。
FEBS Open Bio. 2024 Dec;14(12):2117. doi: 10.1002/2211-5463.13922. Epub 2024 Nov 1.